Acarix AS (Sweden) Investor Sentiment

ACARIX Stock  SEK 0.32  0.01  3.03%   
About 62% of Acarix AS's investor base is looking to short. The analysis of current outlook of investing in Acarix AS suggests that many traders are alarmed regarding Acarix AS's prospects. The current market sentiment, together with Acarix AS's historical and current headlines, can help investors time the market. In addition, many technical investors use Acarix AS stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Acarix Third Quarter 2024 Earnings kr0.019 loss per share - Simply Wall St
Google News at Macroaxis
over two weeks ago at news.google.com         
Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Se...
Google News at Macroaxis
over three months ago at news.google.com         
Acarix Second Quarter 2024 Earnings kr0.02 loss per share - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Acarix AB publishes Interim Report, April - June 2024 - Morningstar
Google News at Macroaxis
over three months ago at news.google.com         
Acarix Announces Shares Are Now Being Traded on the OTCQB Under the Ticker ACIXF - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Acarix announces shares are now being traded on the OTCQB under the ticker ACIXF - Proactive Investo...
Google News at Macroaxis
over three months ago at news.google.com         
Acarix Shares Begin Trading on the US-based OTCQB Market - PR Newswire
Google News at Macroaxis
over three months ago at news.google.com         
Will Acarix Spend Its Cash Wisely - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Acarix Interim Report, January - March 2018 CADScorSystem launched in key markets - Yahoo Lifestyle ...
Google News at Macroaxis
over six months ago at news.google.com         
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic - Clinical Trials Arena
Google News at Macroaxis
over six months ago at news.google.com         
Acarix announces the initiation of the first US-based clinical workflow evaluation study By Investin...
Google News at Macroaxis
over six months ago at news.google.com         
New Health Economic Analysis Presented at ACC Highlights the Acarix CADScor Systems Cost-Effectivene...
Google News at Macroaxis
over six months ago at news.google.com         
ACARIX AB Revenue Breakdown OMXSTOACARIX TradingView - TradingView
Google News at Macroaxis
over six months ago at news.google.com         
ACARIX AB Revenue Breakdown FWB7AC TradingView - TradingView
Google News at Macroaxis
over six months ago at news.google.com         
Acarix receives declarations of intent to exercise warrants of series TO 2 - TradingView
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Acarix AS that are available to investors today. That information is available publicly through Acarix media outlets and privately through word of mouth or via Acarix internal channels. However, regardless of the origin, that massive amount of Acarix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Acarix AS news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Acarix AS relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Acarix AS's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Acarix AS alpha.

Acarix AS Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Acarix Stock analysis

When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon